CS404891A3 - Quinoline derivatives, process of their preparation and pharmaceutical compositions containing said compounds - Google Patents
Quinoline derivatives, process of their preparation and pharmaceutical compositions containing said compounds Download PDFInfo
- Publication number
- CS404891A3 CS404891A3 CS914048A CS404891A CS404891A3 CS 404891 A3 CS404891 A3 CS 404891A3 CS 914048 A CS914048 A CS 914048A CS 404891 A CS404891 A CS 404891A CS 404891 A3 CS404891 A3 CS 404891A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- compounds
- hydrogen
- compound
- quinolinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8813324A FR2637591B1 (fr) | 1988-10-11 | 1988-10-11 | Derives de quinoleinone, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS404891A3 true CS404891A3 (en) | 1992-04-15 |
Family
ID=9370884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS914048A CS404891A3 (en) | 1988-10-11 | 1991-12-23 | Quinoline derivatives, process of their preparation and pharmaceutical compositions containing said compounds |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4983607A (no) |
| EP (1) | EP0364327B1 (no) |
| JP (1) | JPH02157267A (no) |
| KR (1) | KR900006317A (no) |
| AT (1) | ATE71617T1 (no) |
| AU (1) | AU619349B2 (no) |
| CS (1) | CS404891A3 (no) |
| DE (1) | DE68900717D1 (no) |
| DK (1) | DK500189A (no) |
| ES (1) | ES2037980T3 (no) |
| FI (1) | FI91748C (no) |
| FR (1) | FR2637591B1 (no) |
| GR (1) | GR3003921T3 (no) |
| HU (1) | HU204813B (no) |
| IE (1) | IE61830B1 (no) |
| IL (1) | IL91930A (no) |
| NO (1) | NO173058C (no) |
| NZ (1) | NZ230959A (no) |
| PT (1) | PT91939B (no) |
| ZA (1) | ZA897672B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2635105B1 (fr) * | 1988-08-03 | 1991-01-25 | Synthelabo | Derives de piperazine et leur procede de preparation |
| US5457099A (en) * | 1992-07-02 | 1995-10-10 | Sawai Pharmaceutical Co., Ltd. | Carbostyril derivatives and antiallergic agent |
| DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
| CA2156409A1 (en) * | 1993-03-05 | 1994-09-15 | Janusz Jozef Kulagowski | Quinolone derivatives as dopamine d4 ligands |
| DE69427289T2 (de) * | 1993-03-16 | 2001-09-06 | Pfizer Inc., New York | Naphtalinderivate |
| FR2737723B1 (fr) * | 1995-08-09 | 1997-09-05 | Synthelabo | Derives de 1-(2-(1h-inden-3-yl)ethyl)-4-(naphtalen-1-yl)- piperazine, leur preparation et leur application en therapeutique |
| FR2738823B1 (fr) * | 1995-09-15 | 1997-10-31 | Synthelabo | Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique |
| FR2761071B1 (fr) * | 1997-03-20 | 1999-12-03 | Synthelabo | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique |
| FR2761067B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique |
| US6562837B1 (en) * | 1998-10-21 | 2003-05-13 | Korea Institute Of Science & Technology | Use of tetrahydroisoquinoline compounds for the treatment of septicemia |
| MXPA03004037A (es) | 2000-11-07 | 2003-08-19 | Novartis Ag | Derivados de indolilmaleimida como inhibidores de proteina de cinasa c. |
| US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
| US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| TW200803855A (en) * | 2006-02-24 | 2008-01-16 | Kalypsys Inc | Quinolones useful as inducible nitric oxide synthase inhibitors |
| JP2011520956A (ja) * | 2008-05-20 | 2011-07-21 | アストラゼネカ・アクチエボラーグ | 不安大うつ病性障害を処置する方法 |
| MA41168A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54128588A (en) * | 1978-03-29 | 1979-10-05 | Dainippon Pharmaceut Co Ltd | Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline |
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| US4284768A (en) * | 1980-07-02 | 1981-08-18 | American Home Products Corporation | 1,2-Dihydro-4-amino-2-oxo-3-quinoline-carboxylic acid derivatives |
| GB8827189D0 (en) * | 1988-11-21 | 1988-12-29 | Fujisawa Pharmaceutical Co | 2(1h)-quinolinone compounds processes for preparation thereof & pharmaceutical composition comprising same |
-
1988
- 1988-10-11 FR FR8813324A patent/FR2637591B1/fr not_active Expired - Fee Related
-
1989
- 1989-10-02 AT AT89402700T patent/ATE71617T1/de not_active IP Right Cessation
- 1989-10-02 ES ES198989402700T patent/ES2037980T3/es not_active Expired - Lifetime
- 1989-10-02 EP EP89402700A patent/EP0364327B1/fr not_active Expired - Lifetime
- 1989-10-02 DE DE8989402700T patent/DE68900717D1/de not_active Expired - Lifetime
- 1989-10-09 ZA ZA897672A patent/ZA897672B/xx unknown
- 1989-10-10 IE IE326589A patent/IE61830B1/en not_active IP Right Cessation
- 1989-10-10 KR KR1019890014520A patent/KR900006317A/ko not_active Application Discontinuation
- 1989-10-10 FI FI894803A patent/FI91748C/fi not_active IP Right Cessation
- 1989-10-10 NZ NZ230959A patent/NZ230959A/en unknown
- 1989-10-10 PT PT91939A patent/PT91939B/pt not_active IP Right Cessation
- 1989-10-10 IL IL91930A patent/IL91930A/xx not_active IP Right Cessation
- 1989-10-10 US US07/417,970 patent/US4983607A/en not_active Expired - Lifetime
- 1989-10-10 AU AU42750/89A patent/AU619349B2/en not_active Ceased
- 1989-10-10 HU HU895268A patent/HU204813B/hu not_active IP Right Cessation
- 1989-10-10 NO NO894036A patent/NO173058C/no not_active IP Right Cessation
- 1989-10-10 DK DK500189A patent/DK500189A/da not_active Application Discontinuation
- 1989-10-11 JP JP1266051A patent/JPH02157267A/ja active Pending
-
1991
- 1991-12-23 CS CS914048A patent/CS404891A3/cs unknown
-
1992
- 1992-02-27 GR GR920400344T patent/GR3003921T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO894036D0 (no) | 1989-10-10 |
| JPH02157267A (ja) | 1990-06-18 |
| FR2637591A1 (fr) | 1990-04-13 |
| IE893265L (en) | 1990-04-11 |
| NO173058C (no) | 1993-10-20 |
| NZ230959A (en) | 1990-12-21 |
| HU895268D0 (en) | 1990-01-28 |
| FI91748C (fi) | 1994-08-10 |
| DK500189D0 (da) | 1989-10-10 |
| PT91939B (pt) | 1995-05-31 |
| DK500189A (da) | 1990-04-12 |
| HUT51612A (en) | 1990-05-28 |
| IE61830B1 (en) | 1994-11-30 |
| EP0364327B1 (fr) | 1992-01-15 |
| EP0364327A1 (fr) | 1990-04-18 |
| AU619349B2 (en) | 1992-01-23 |
| FR2637591B1 (fr) | 1992-10-23 |
| IL91930A0 (en) | 1990-06-10 |
| KR900006317A (ko) | 1990-05-07 |
| ATE71617T1 (de) | 1992-02-15 |
| NO173058B (no) | 1993-07-12 |
| GR3003921T3 (no) | 1993-03-16 |
| FI894803A (fi) | 1990-04-12 |
| PT91939A (pt) | 1990-04-30 |
| ES2037980T3 (es) | 1993-07-01 |
| ZA897672B (en) | 1990-07-25 |
| DE68900717D1 (de) | 1992-02-27 |
| US4983607A (en) | 1991-01-08 |
| HU204813B (en) | 1992-02-28 |
| FI91748B (fi) | 1994-04-29 |
| FI894803A0 (fi) | 1989-10-10 |
| NO894036L (no) | 1990-04-17 |
| IL91930A (en) | 1993-08-18 |
| AU4275089A (en) | 1990-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS404891A3 (en) | Quinoline derivatives, process of their preparation and pharmaceutical compositions containing said compounds | |
| RU2182150C2 (ru) | Производные бензимидазола, антигистаминная фармацевтическая композиция и способ лечения аллергических заболеваний | |
| US4668686A (en) | Imidazoquinoline antithrombrogenic cardiotonic agents | |
| US5753663A (en) | Pyrimidine derivatives | |
| US5010079A (en) | Indolone derivatives, their preparation and their application in therapy | |
| PT99154A (pt) | Processo para a preparacao de derivados de indole, uteis como agentes anti-alergicos e anti-inflamatorios | |
| JPH11501640A (ja) | ５−ｈｔ▲下４▼拮抗作用を有するジ−置換１，４−ピペリジンエステル類及びアミド類 | |
| JP2017014270A (ja) | 光学活性ピペリジン誘導体の酸付加塩及びその製法 | |
| JPS6289679A (ja) | ピペリジン誘導体 | |
| PT96952A (pt) | Processo para a preparacao de derivados de 4-(aminometil)-piperidina e de composicoes farmaceuticas que os contem | |
| JP3057095B2 (ja) | イサチン誘導体、その製造方法及びその使用方法 | |
| CZ51694A3 (en) | Benzoxazine derivatives, process of their preparation and pharmaceutical composition in which said derivatives are comprised | |
| US20090306144A1 (en) | Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents | |
| HU201543B (en) | Process for production of derivatives of 2-(/piperin-4-il/-methil/)-1,2,3,4-tetrahydro-izoquinoline and medical compositions containing them | |
| US5597819A (en) | Phenothiazine cytokine inhibitors | |
| CS248020B2 (en) | Production method of the (+)-enantiomere or (+-)-racemical 4a,9b-trans-hexahydro-1h-pyridoindole derivatives | |
| US7910591B2 (en) | Piperazine derivatives of alkyl oxindoles | |
| EP1751106B1 (en) | Piperazine derivatives of alkyl oxindoles | |
| US6436987B1 (en) | Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid | |
| HU215598B (hu) | Eljárás optikailag aktív 1-fenil-pirrolidon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására |